Hydrochlorothiazide
Home / API - Commercial / Hydrochlorothiazide
Therapeutic Category
- Diuretic
Innovator Brand
ESIDREX , HYDRODIURIL
GMP
Available
DMF
Available
Filed
Under Filing
-
Sample
Available
Indication
Hydrochlorothiazide is indicated alone or in combination for the management of edema associated with congestive heart failure, hepatic cirrhosis, nephrotic syndrome, acute glomerulonephritis, chronic renal failure, and corticosteroid and estrogen therapy. Hydrochlorothiazide is also indicated alone or in combination for the management of hypertension.
Disclaimer: CTX Lifesciences respects patent laws and conventions of pharmaceuticals as applicable in different countries.
API/Substances covered by patent are not offered to the countries where the patent law is in force. However, the final responsibility lies with the customer.